Replies to post #17800 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Speaks for itself,

Boing,

If you were investing in words and if-comes there's no question that Momenta would be a great investment.

Sadly we invest in currency and from that point momenta has been nothing but a disaster. If the funds were invested into any other vehicle you would be in a much better position today. Just plot out the IBB or NAZ against this pig and you'll see what was sacrificed.

But of course, this stock will turn starting today.

[DewDiligence]

Re: M710 (probably Xolair)

If the list you posted is correct, then M710 (the codename of the next FoB in the MYL-MNTA partnership to enter the clinic) is presumably Xolair.

MNTA previously disclosed that M710 was for an autoimmune/inflammation indication, and Xolair fits the bill. Also, like Orencia (M834), Xolair is a drug where the number of FoB players will be few. (I'm not aware of another Xolair-FoB program in development, although there may be one.)